Triple‐negative breast cancer (TNBC), defined by lacking oestrogen receptor (ER), progesterone receptor (PR), and HER2 (Human Epidermal Growth Factor Receptor 2) expression, represents the most aggressive subtype of breast cancer. Here, ERBB2 is linked to breast carcinoma.